APOE4 gene linked to early onset Alzheimer’s, target for therapeutic intervention

FHS
May 8, 2024
5:20 am

A study published in Nature Medicine delineates how APOE4 homozygosity distinctly accelerates Alzheimer’s disease pathology and biomarkers from the age of 55, suggesting a unique form of the disease and a potential focus for targeted therapies.

Pα+ Psychedelic Bulletin #174: Psilocybin Outperforms Escitalopram After 6 Months… or Does It? Survey Results Reveal Healthcare Practitioner Attitudes to Psychedelics; and more… – Psychedelic Alpha

In this Issue Six-Month Follow-Up Data Shows Psilocybin Outperforms Escitalopram… or Does It? Survey Reveals Healthcare Practitioner Attitudes to Psychedelics MIND Foundation Plots 700-Patient Psilocybin

September 27, 2024

Simple interview technique could help detect early signs of dementia

Research at the Florida State University College of Medicine has identified a potential low-cost method for predicting if a person is at risk of developing

August 4, 2023

Neuroscientists link visual perception shifts to walking rhythm

For the first time, neuroscientists have established a link between shifts in our visual perception and the cadence of our steps while walking.

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.